The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Procalcitonin as a biomarker of infectious diseases

  • Lee, Hyuck (Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital)
  • Published : 2013.05.01
⟨ Previous Next ⟩

Abstract

Traditional biomarkers, including C-reactive protein, leukocytes, erythrocyte sedimentation rate, and clinical signs and symptoms, are not sufficiently sensitive or specific enough to guide treatment decisions in infectious febrile diseases. Procalcitonin (PCT) is synthesized by a large number of tissues and organs in response to invasion by pathogenic bacteria, fungi, and some parasites. A growing body of evidence supports the use of PCT as a marker to improve the diagnosis of bacterial infections and to guide antibiotic therapy. Clinically, PCT levels may help guide the need for empirical antibiotic therapy, source control for infections, and duration of antibiotic therapy. The aim of this review is to summarize the current evidence for PCT in different infections and clinical settings, and to discuss the reliability of this marker in order to provide physicians with an overview of the potential for PCT to guide antibiotic therapy.

Keywords

References

  1. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011;9:107. https://doi.org/10.1186/1741-7015-9-107
  2. Muller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7:10. https://doi.org/10.1186/1471-2334-7-10
  3. Chung TP, Laramie JM, Province M, Cobb JP. Functional genomics of critical illness and injury. Crit Care Med 2002;30(1 Suppl):S51-S57. https://doi.org/10.1097/00003246-200201001-00007
  4. Bagshaw SM, Bellomo R. Early diagnosis of acute kidney injury. Curr Opin Crit Care 2007;13:638-644. https://doi.org/10.1097/MCC.0b013e3282f07570
  5. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012;55:651-662. https://doi.org/10.1093/cid/cis464
  6. Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med 2012;38:940-949. https://doi.org/10.1007/s00134-012-2563-7
  7. Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol 2010;48:2325-2329. https://doi.org/10.1128/JCM.00655-10
  8. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections: hope for hype? Swiss Med Wkly 2009;139:318-326.
  9. Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003;144:5578-5584. https://doi.org/10.1210/en.2003-0854
  10. Morgenthaler NG, Struck J, Fischer-Schulz C, Seidel-Mueller E, Beier W, Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin Lab 2002;48:263-270.
  11. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007;30:556-573. https://doi.org/10.1183/09031936.00166106
  12. Pfaff lin A, Schleicher E. Inf lammation markers in point-of-care testing (POCT). Anal Bioanal Chem 2009;393:1473-1480. https://doi.org/10.1007/s00216-008-2561-3
  13. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998;24:888-889. https://doi.org/10.1007/s001340050683
  14. Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from noninfectious fever. J Infect 2010;60:409-416. https://doi.org/10.1016/j.jinf.2010.03.016
  15. Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977-983. https://doi.org/10.1097/00003246-200004000-00011
  16. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin- 8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402. https://doi.org/10.1164/ajrccm.164.3.2009052
  17. Aabenhus R, Jensen JU. Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet? Prim Care Respir J 2011;20:360-367. https://doi.org/10.4104/pcrj.2011.00064
  18. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010;8:575-587. https://doi.org/10.1586/eri.10.25
  19. Manian FA. Use of procalcitonin to guide duration of antimicrobial therapy in intensive care units: proceed with caution. Clin Infect Dis 2012;54:578.
  20. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-217. https://doi.org/10.1016/S1473-3099(07)70052-X
  21. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003. https://doi.org/10.1097/01.CCM.0000226413.54364.36
  22. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999;3:45-50. https://doi.org/10.1186/cc306
  23. Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 2011;27:253-263. https://doi.org/10.1016/j.ccc.2011.01.002
  24. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012;25:609-634. https://doi.org/10.1128/CMR.00016-12
  25. Li H, Luo YF, Blackwell TS, Xie CM. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections. Antimicrob Agents Chemother 2011;55:5900-5906. https://doi.org/10.1128/AAC.00335-11
  26. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302:1059-1066. https://doi.org/10.1001/jama.2009.1297
  27. Gac AC, Parienti JJ, Chantepie S, et al. Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia. Leuk Res 2011;35:1294-1296. https://doi.org/10.1016/j.leukres.2011.05.035
  28. Perrakis A, Yedibela S, Schellerer V, Hohenberger W, Muller V. Procalcitonin in the setting of complicated postoperative course after liver transplantation. Transplant Proc 2010;42:4187-4190. https://doi.org/10.1016/j.transproceed.2010.08.070
  29. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008;36:396-407. https://doi.org/10.1007/s15010-008-7374-y
  30. Jereb M, Muzlovic I, Hojker S, Strle F. Predictive value of serum and cerebrospinal f luid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 2001;29:209-212. https://doi.org/10.1007/s15010-001-1165-z
  31. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000;28:1828-1832. https://doi.org/10.1097/00003246-200006000-00024
  32. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463-474. https://doi.org/10.1016/S0140-6736(09)61879-1
  33. Kopterides P, Siempos, II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2010;38:2229-2241. https://doi.org/10.1097/CCM.0b013e3181f17bf9
  34. Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 2009;34:1364-1375. https://doi.org/10.1183/09031936.00053209
  35. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008;177:498-505. https://doi.org/10.1164/rccm.200708-1238OC
  36. Riedel S. Procalcitonin and antibiotic therapy: can we improve antimicrobial stewardship in the intensive care setting? Crit Care Med 2012;40:2499-2500. https://doi.org/10.1097/CCM.0b013e318256b7da
  37. Kim HA, Jeon JY, An JM, Koh BR, Suh CH. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin. J Rheumatol 2012;39:728-734. https://doi.org/10.3899/jrheum.111044
  38. Hunziker S, Hugle T, Schuchardt K, et al. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am 2010;92:138-148. https://doi.org/10.2106/JBJS.H.01600
  39. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inf lammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008;36:941-952. https://doi.org/10.1097/CCM.0B013E318165BABB

Cited by

  1. Value of serum procalcitonin and interleukin‐6 in patients with bullous impetigo and staphylococcal scalded skin syndrome vol.41, pp.11, 2013, https://doi.org/10.1111/1346-8138.12638
  2. Endocan Levels in Peripheral Blood Predict Outcomes of Acute Respiratory Distress Syndrome vol.2014, pp.None, 2013, https://doi.org/10.1155/2014/625180
  3. Biomarkers for Sepsis vol.2014, pp.None, 2013, https://doi.org/10.1155/2014/547818
  4. Return to play after acute infectious disease in football players vol.32, pp.13, 2014, https://doi.org/10.1080/02640414.2014.898861
  5. Comparing the anti-inflammatory effects of Simvastatin and Rosuvastatin by measuring IL-1β, IL-6 and TNF-α levels using a murinic caecal ligation and puncture induced sepsis model / Compara vol.22, pp.4, 2013, https://doi.org/10.2478/rrlm-2014-0037
  6. Comparing the anti-inflammatory effects of Simvastatin and Rosuvastatin by measuring IL-1β, IL-6 and TNF-α levels using a murinic caecal ligation and puncture induced sepsis model / Compara vol.22, pp.4, 2013, https://doi.org/10.2478/rrlm-2014-0037
  7. Is Procalcitonin a Diagnostic and/or Prognostic Marker in Sepsis? vol.23, pp.1, 2013, https://doi.org/10.1097/ipc.0000000000000187
  8. Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia vol.56, pp.1, 2013, https://doi.org/10.3109/10428194.2014.911864
  9. Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia vol.56, pp.1, 2013, https://doi.org/10.3109/10428194.2014.911864
  10. Clinical Value of Procalcitonin in Patients with Spinal Infection vol.58, pp.3, 2013, https://doi.org/10.3340/jkns.2015.58.3.271
  11. Early Drastic Decrease in White Blood Count Can Predict Uroseptic Shock Induced by Upper Urinary Tract Endoscopic Lithotripsy: A Translational Study vol.193, pp.6, 2013, https://doi.org/10.1016/j.juro.2015.01.071
  12. Biomarkers of sepsis: Recent advancements vol.12, pp.4, 2013, https://doi.org/10.1016/j.apme.2015.11.003
  13. Valuable hematological indicators for the diagnosis and severity assessment of Chinese children with community-acquired pneumonia : Prealbumin vol.95, pp.47, 2013, https://doi.org/10.1097/md.0000000000005452
  14. Procalcitonin and C-reactive protein-based decision tree model for distinguishing PFAPA flares from acute infections vol.16, pp.2, 2016, https://doi.org/10.17305/bjbms.2016.974
  15. Procalcitonin as a biomarker of bacterial infection in pediatric patients after congenital heart surgery vol.9, pp.2, 2013, https://doi.org/10.4103/0974-2069.180665
  16. Serum Procalcitonin as a Useful Serologic Marker for Differential Diagnosis between Acute Gouty Attack and Bacterial Infection vol.57, pp.5, 2016, https://doi.org/10.3349/ymj.2016.57.5.1139
  17. Procalcitonin is a strong predictor of urine culture results in patients with obstructing ureteral stones: A prospective, pilot study vol.8, pp.3, 2013, https://doi.org/10.4103/0974-7796.184877
  18. Prognostic factors associated with mortality in patients with septic arthritis: a descriptive cohort study vol.46, pp.1, 2013, https://doi.org/10.3109/03009742.2016.1164241
  19. Fever in Patients with Cancer vol.24, pp.2, 2017, https://doi.org/10.1177/107327481702400212
  20. Evolution of laboratory markers for systemic bacterial infections vol.89, pp.11, 2013, https://doi.org/10.17116/terarkh20178911105-110
  21. Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis vol.17, pp.None, 2017, https://doi.org/10.1186/s12879-017-2622-3
  22. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities vol.23, pp.47, 2017, https://doi.org/10.3748/wjg.v23.i47.8283
  23. A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma vol.141, pp.4, 2013, https://doi.org/10.1016/j.jaci.2017.04.021
  24. Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/9120878
  25. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers vol.67, pp.4, 2013, https://doi.org/10.1016/j.jvs.2017.02.060
  26. Adenovirus infection: beware of plasma procalcitonin levels in children vol.103, pp.6, 2013, https://doi.org/10.1136/archdischild-2017-314307
  27. A Flowthrough Assay for Rapid Bedside Stratification of Bloodstream Bacterial Infection in Critically Ill Patients: a Pilot Study vol.56, pp.9, 2013, https://doi.org/10.1128/jcm.00408-18
  28. The role of serum procalcitonin in the differential diagnosis of pneumonia from pulmonary edema among the patients with pulmonary infiltrates on chest radiography vol.97, pp.47, 2013, https://doi.org/10.1097/md.0000000000013348
  29. The Importance of Serological Procalcitonin Levels After Autologous Microsurgical Transplantation : vol.30, pp.3, 2013, https://doi.org/10.1097/scs.0000000000005431
  30. Procalcitonin and Its Limitations: Why a Biomarker's Best Isn't Good Enough vol.3, pp.4, 2013, https://doi.org/10.1373/jalm.2017.025916
  31. Factors Predicting Bacterial Infection in Out-of-Hospital Cardiac Arrest Patients Undergoing Targeted Temperature Management vol.9, pp.3, 2013, https://doi.org/10.1089/ther.2018.0033
  32. Procalcitonin and Neutrophil Lymphocyte Ratio After Spinal Instrumentation Surgery vol.44, pp.23, 2019, https://doi.org/10.1097/brs.0000000000003157
  33. Combinatorial Assessment of Serum Inflammation Reactants in Patients with Acute Urticaria Accompanied by Systemic Symptoms vol.65, pp.1, 2020, https://doi.org/10.4103/ijd.ijd_286_18
  34. Diagnostic Accuracy of Procalcitonin, Neutrophil-to-Lymphocyte Ratio, and C-Reactive Protein in Detection of Bacterial Infections and Prediction of Outcome in Nonneutropenic Febrile Patients with Lung vol.2020, pp.None, 2013, https://doi.org/10.1155/2020/2192378
  35. diagnostic utility of procalcitonin in children with infectious complications during chemotherapy-induced neutropenia: single center experience, literature review vol.15, pp.1, 2013, https://doi.org/10.17650/1818-8346-2020-15-1-65-72
  36. Serum procalcitonin concentrations in dogs with induced endotoxemia vol.34, pp.2, 2013, https://doi.org/10.1111/jvim.15711
  37. Cost Impact Model of a Novel Multi-mRNA Host Response Assay for Diagnosis and Risk Assessment of Acute Respiratory Tract Infections and Sepsis in the Emergency Department vol.7, pp.1, 2013, https://doi.org/10.36469/jheor.2020.12637
  38. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak vol.36, pp.13, 2013, https://doi.org/10.1093/bioinformatics/btaa285
  39. Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients vol.100, pp.22, 2013, https://doi.org/10.1097/md.0000000000026131
  40. Procalcitonin, C-Reactive Protein, and Fibrinogen Levels in Cases With Mechanic Bowel Obstruction and Their Changing in Relation With the Duration of Obstruction: An Experimental Study vol.105, pp.1, 2021, https://doi.org/10.9738/intsurg-d-15-00122.1
  41. Clinical Outcome Predictive Value of Procalcitonin in Patients Suspected with Infection in the Emergency Department vol.2021, pp.None, 2013, https://doi.org/10.1155/2021/2344212
  42. Temperature Plays an Essential Regulatory Role in the Tumor Immune Microenvironment vol.17, pp.2, 2013, https://doi.org/10.1166/jbn.2021.3030
  43. The Effect of Pre-TURP Bladder Irrigation with 0.2% Chlorhexidine in Patients with Foley Catheter Regarding Postoperative Bacteremia Decrease vol.16, pp.1, 2013, https://doi.org/10.5812/archcid.101296
  44. Blood Procalcitonin Level as a Diagnostic Marker of Pediatric Bacterial Meningitis: A Systematic Review and Meta-Analysis vol.11, pp.5, 2013, https://doi.org/10.3390/diagnostics11050846
  45. Proadrenomedullin Predicts Severe Disease in Children With Suspected Community-acquired Pneumonia vol.73, pp.3, 2013, https://doi.org/10.1093/cid/ciaa1138
  46. Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis vol.10, pp.8, 2013, https://doi.org/10.1093/jpids/piab027
  47. Impact of Pharmacist-Directed Simplified Procalcitonin Algorithm on Antibiotic Therapy in Critically Ill Patients With Sepsis vol.56, pp.5, 2013, https://doi.org/10.1177/0018578720925385
  48. Dietary Supplementation of Carob and Whey Modulates Gut Morphology, Hemato-Biochemical Indices, and Antioxidant Biomarkers in Rabbits vol.24, pp.10, 2021, https://doi.org/10.1089/jmf.2020.0185
  49. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease vol.21, pp.1, 2013, https://doi.org/10.1186/s12879-021-06804-2